Womenz Magazine

This common antibiotic drug can cause deafness, study shows

Gentamicin is a widely used antibiotic in U.S. hospitals to treat a variety of bacterial infections.

It’s a popular drug in developing countries because it is highly effective and inexpensive.

But researchers estimate that up to 20% of patients who are treated with it experience some degree of irreversible hearing loss.

In a recent study at Stanford Medicine, researchers found a new way to purify gentamicin and to reduce the risk that it will cause deafness.

They found a relatively inexpensive way to reformulate the drug, which belongs to a class of antibiotics called aminoglycosides, to be safer.

The study is published in the Proceedings of the National Academy of Sciences. One author is Alan Cheng, M.D.

Currently, the FDA’s instructions for how to make aminoglycosides are making people go deaf.

Aminoglycosides have been in use since the 1950s. The drugs don’t need to be refrigerated, which keeps the costs of storing them low.

Despite new antibiotics, their use remains commonplace as they are cheap and potent.

The gentamicin used in hospitals today is a mixture of five different subtypes of the antibiotic grown together in the same mixture.

The mixture also includes as much as 10% impurities.

In the study, the team figured out how to chemically separate each of the subtypes so they could be tested separately.

They found the least toxic subtype as C2b, and the most toxic as sisomicin.

Both C2b and sisomicin showed the same highly effective antimicrobial properties comparable to the mixture as a whole.

The researchers also found that by removing impurities from the mixture, toxicity to the ear tissue was reduced.

The researchers say that when a drug causes hearing loss, it is devastating, and it’s especially disturbing when it happens to a young child, as they rely on hearing to acquire speech.

Their simple method of reformulating the drug should be put to use as soon as possible.

The team will be writing to the Food and Drug Administration to recommend changes to the organization’s requirements for how drug companies make gentamicin.

Related posts

Proper Apple Pie

Alex R.

World won’t be protected from Covid for six years, expert predicts in dire warning

alex

This drug may make vaccines more effective in older people

alex